arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ionis Pharmaceuticals, Inc.

IONS Health Care Biotechnology: Pharmaceutical Preparations
$74.48
▼ -0.9% Today
as of Jun 7, 07:18 ET
Last 30 days +3.76% Apr 28 → Jun 05
$71.31 $73.00 $74.69 $76.38 $78.07 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$75.24
High
$75.96
Low
$73.82
Volume
$2M
Avg Vol
$2M
Mkt Cap
$12.8B
P/E (TTM)
Beta
52w High
$86.74
52w Low
$34.78
Div Yield
Shares Out
$166M

Overview

52-week range
$35
$87
76% of range
Avg surprise (last 1)
+19.8%
Avg reaction (last 1)
+3.0%
100% positive
Latest IV / EM
42%
EM ±5.8% · $75 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.16$-0.69$-0.23$0.24$0.70 Actual $-0.60Actual $-1.03Actual $-0.98Actual $-0.45Actual $-0.95Actual $-0.93Est $-1.16Actual $0.70Actual $-0.80Actual $-0.56 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-147M$-78M$-9M$61M$130M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-0.56 financials
Tue Sep 30, 2025Sep 2025 $-0.80 financials
Mon Jun 30, 2025Jun 2025 $0.70 financials
Wed Apr 30, 2025Mar/2025 $-0.93 $-1.16 +19.8% +3.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.95 financials
Sun Jun 30, 2024Jun 2024 $-0.45 financials
Sun Mar 31, 2024Mar 2024 $-0.98 financials
Sat Sep 30, 2023Sep 2023 $-1.03 financials
Fri Jun 30, 2023Jun 2023 $-0.60 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$3M$2M$4M$1M$1M$4M
Gross profit
Operating income$-117M$-160M$140M$-147M$-149M$-66M
Net income$-93M$-129M$124M$-147M$-140M$-66M
EPS (diluted)$-0.56$-0.80$0.70$-0.93$-0.95$-0.45

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$173M$372M$338M$297M$264M$242M$335M$294M
Inventory$6M$10M$10M$8M$12M$13M$28M$29M
Total current assets$2.94B$2.99B$2.52B$2.58B$2.42B$2.62B$2.71B$2.33B
Total assets$3.45B$3.52B$3.03B$2.99B$2.81B$3.00B$3.08B$2.69B
Long-term debt
Total liabilities$2.96B$3.03B$2.42B$2.35B$2.34B$2.42B$2.42B$2.43B
Total equity$491M$489M$618M$632M$476M$588M$662M$264M

Implied volatility — last 90 days

36%39%41%44%46% Jun 07 — IV 42% · EM ±5.8%

Sector peers